0001209191-22-035010.txt : 20220608
0001209191-22-035010.hdr.sgml : 20220608
20220608160606
ACCESSION NUMBER: 0001209191-22-035010
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220607
FILED AS OF DATE: 20220608
DATE AS OF CHANGE: 20220608
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Angotti Vincent J.
CENTRAL INDEX KEY: 0001700225
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35068
FILM NUMBER: 221003552
MAIL ADDRESS:
STREET 1: C/O ACELRX PHARMACEUTICALS, INC.
STREET 2: 351 GALVESTON DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACELRX PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001427925
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 25821 INDUSTRIAL BOULEVARD
STREET 2: SUITE 400
CITY: HAYWARD
STATE: CA
ZIP: 94545
BUSINESS PHONE: 650-216-3500
MAIL ADDRESS:
STREET 1: 25821 INDUSTRIAL BOULEVARD
STREET 2: SUITE 400
CITY: HAYWARD
STATE: CA
ZIP: 94545
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-07
0
0001427925
ACELRX PHARMACEUTICALS INC
ACRX
0001700225
Angotti Vincent J.
C/O ACELRX PHARMACEUTICALS, INC.
25821 INDUSTRIAL BLVD., SUITE 400
HAYWARD
CA
94545
1
1
0
0
Chief Executive Officer
Common Stock
2022-06-07
4
P
0
46400
0.2227
A
1016919
D
The price reported on Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.2187 to $0.2241 on June 7, 2022. The reporting person will provide upon request to the SEC, the issuer or security holder of Issuer, full information regarding the number of shares purchased at each separate price.
/s/ Martha Adler, Attorney-In-Fact
2022-06-08